Rubin Jonathan 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Sep 26, 2025
Insider Transaction Report
Form 4
Rubin Jonathan
SVP, Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2025-09-25$46.21/sh−840$38,816→ 11,015 total - Exercise/Conversion
Performance Share Unit
2025-09-25−1,875→ 0 totalExercise: $0.00→ Common Stock (1,875 underlying) - Exercise/Conversion
Common Stock
2025-09-25+1,875→ 11,855 total
Footnotes (3)
- [F1]Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024.
- [F2]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
- [F3]On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.